V. Novakova, P. Zimcik, M. Miletin, K. Kopecky, Z. Musil
FULL PAPER
was continued for 3 h. The crude product was purified by column
chromatography on silica (chloroform) to obtain a pale-yellow so-
was evaporated under reduced pressure, and the residue was ex-
tracted with chloroform and purified by column chromatography
lid (242.4 mg, 51%). M.p. 118.1–119.4 °C. 1H NMR (300 MHz, on silica (toluene), yielding a colourless oil that solidified after a
CDCl3, 25 °C): δ = 0.99 (t, J = 7.4 Hz, 6 H, CH3), 1.48 (sext., J =
while (200 mg, 37%). M.p. 96–97 °C. 1H NMR (300 MHz, CDCl3,
7.5 Hz, 4 H, CH2CH3), 1.82 (p, J = 7.1 Hz, 4 H, OCH2CH2), 4.50 25 °C): δ = 1.01 (s, 18 H, CH3), 3.09 (s, 4 H, CH2) ppm. 13C NMR
(t, J = 6.7 Hz, 4 H, OCH2), 8.72 (s, 2 H, ArH) ppm. 13C NMR (75 MHz, CDCl3, 25 °C): δ = 159.79, 129.51, 113.31, 46.89, 34.08,
(75 MHz, CDCl3, 25 °C): δ = 163.35, 147.79, 141.65, 137.30, 29.69 ppm. IR (KBr): ν = 3478, 2961, 2904, 2869, 2241, 1524, 1472,
˜
116.66, 114.15, 67.45, 30.35, 18.99, 13.63 ppm. IR (KBr): ν = 3468,
1430, 1396, 1378, 1320, 1229, 1199, 1129, 851, 670 cm–1. C16H22N4
˜
3096, 3067, 3045, 2961, 2937, 2875, 2239 (CN), 1747, 1471, 1435, (270.37): calcd. C 71.08, H 8.20, N 20.72; found C 71.03, H 8.64,
1360, 1336, 1279, 1220, 1195, 1135, 1073, 936 cm–1. C20H20N4O4 N 20.51.
(380.40): calcd. C 63.15, H 5.30, N 14.73; found C 63.99, H 5.74,
N 14.83.
5,6-Bis(2,6-diisopropylphenoxy)pyrazine-2,3-dicarbonitrile (12): 2,6-
Diisopropylphenol (446 mg, 2.5 mmol) was stirred for 15 min at
2,3-Dineopentylquinoxaline-6,7-dicarbonitrile (3): 4,5-Diaminoph-
thalonitrile (1; 632 mg, 4 mmol) was added to a stirred solution
of 2,2,7,7-tetramethyloctane-4,5-dione (400 mg, 2 mmol) in glacial
acetic acid (20 mL), and the mixture was heated at reflux for 9 h.
The solvent was evaporated, and the product was purified by col-
umn chromatography on silica (chloroform), yielding a white solid
(460 mg, 71%). M.p. 154–157 °C (MeOH). 1H NMR (300 MHz,
CDCl3, 25 °C): δ = 1.04 (s, 18 H, CH3), 3.10 (s, 4 H, CH2), 8.50 (s,
2 H, ArH) ppm. 13C NMR (75 MHz, CDCl3, 25 °C): δ = 161.04,
140.89, 136.66, 115.16, 113.20, 47.54, 34.08, 29.83 ppm. IR (KBr):
room temperature in 1 aqueous NaOH (2.4 mL, 2.4 mmol). 5,6-
Dichloropyrazine-2,3-dicarbonitrile[35] (200 mg, 1 mmol) in THF
(15 mL) was added dropwise, and the mixture was stirred for
15 min at room temperature. The crude product was concentrated
to dryness, and the brownish-yellow solid was washed thoroughly
with water and purified by column chromatography on silica (tolu-
ene/hexane, 1:1), yielding a white solid (404 mg, 83%). M.p. 208.5–
209.5 °C (MeOH) {ref.[25] m.p. 253 °C (n-hexane)}. 1H NMR
(300 MHz, CDCl3, 25 °C): δ = 7.39–7.24 (m, 6 H, aromH), 2.82
(sept., J = 7 Hz, 4 H, CH), 1.23 (d, J = 7 Hz, 24 H, CH3) ppm.
13C NMR (75 MHz, CDCl3, 25 °C): δ = 23.2, 28.0, 112.6, 124.2,
ν = 3447, 2965, 2903, 2866, 2240 (CN), 1556, 1473, 1398, 1366,
˜
1335, 1226, 1200, 1131 cm–1. C20H24N4 (320.43): calcd. C 74.97, H
7.55, N 17.48; found C 74.48, H 7.79, N 17.65.
124.6, 127.6, 139.8, 146.3, 151.1 ppm. IR (KBr): ν = 3068, 3032,
˜
2967, 2930, 2871, 2360, 2344, 2237, 1545, 1460, 1441, 1403, 1385,
1357, 1331, 1258, 1233, 1142, 1112, 1089, 1062, 937, 849, 793,
750 cm–1. C30H34N4O (482.62): calcd. C 74.66, H 7.10, N 11.61;
found C 74.40, H 7.31, N 11.99.
2,3-Bis(tert-butylsulfanyl)quinoxaline-6,7-dicarbonitrile (6): 2,3-
Dichloroquinoxaline-6,7-dicarbonitrile (4; 120 mg, 0.48 mmol) was
dissolved in THF (50 mL), and this solution was poured into a
solution of 2-methylpropan-2-thiol (104 mg, 1.2 mmol) in 1
aqueous NaOH (1 mL). This solution was stirred for 15 min at
room temperature. The crude product was purified on silica (tolu-
ene/chloroform, 4:1) to gain a bright yellow solid (127 mg, 74%).
General Procedure for the Synthesis of Zinc(II) Tetra[6,7]quinoxal-
inoporphyrazines TQP1–4: Magnesium turnings and a small crystal
of iodine were heated at reflux for 3 h in anhydrous butanol. The
appropriate precursor (2, 3, 5 or 6) was added, and the reaction
mixture was heated at reflux for 3 h (TQP1 and TQP2) or 6 h
(TQP3 and TQP4). The mixture was left to cool down, and it was
then poured into water/methanol/acetic acid 5:5:1 (6:3:1 in the case
of TQP4) (30–100 mL) and stirred for 30 min at room temperature.
The precipitate (MgTQP) was collected. Purification of crude
MgTQP and demetallation to metal-free TQP is mentioned at each
compound preparation. Thereafter, metal-free TQP was dissolved
in pyridine, anhydrous zinc acetate in DMF was added and the
reaction mixture was heated at reflux for 2 h (6 h in the case of
TQP4). The mixture was concentrated under reduced pressure and
water was added. The solid was collected and purified by column
chromatography on silica (except TQP2 and TQP4). Mobile phases
are mentioned bellow.
1
M.p. 219–221 °C. H NMR (300 MHz, CDCl3, 25 °C): δ = 1.72 (s,
18 H, CH3), 8.25 (s, 2 H, ArH) ppm. 13C NMR (75 MHz, CDCl3,
25 °C):
δ = 161.82, 139.21, 134.44, 115.39, 112.10, 51.53,
29.74 ppm. IR (KBr): ν = 3522, 2996, 2964, 2923, 2904, 2864, 2621,
˜
2235 (CN), 1509, 1477, 1456, 1389, 1366, 1360, 1268, 1221, 1166,
1150, 1113, 1030, 899 cm–1. C18H20N4S2 (356.51): calcd. C 60.64,
H 5.65, N 15.72; found C 60.42, H 5.75, N 15.68.
2,3-Bis(2,6-diisopropylphenoxy)quinoxaline-6,7-dicarbonitrile
(7):
2,6-Diisopropylphenol (890 mg, 5 mmol) was added to 1 aqueous
NaOH (5 mL), and the mixture was stirred for 40 min at room
temperature. This solution was then dropped portionwise into a
THF (100 mL) suspension of 2,3-dichloroquinoxaline-6,7-dicar-
bonitrile (4; 470 mg, 1.9 mmol). The mixture was stirred at room
temperature for 70 min and THF was then evaporated. The suspen-
sion was diluted with water and filtered. Crude product was puri-
fied by column chromatography on silica (toluene) and recrys-
tallized from MeOH, yielding a white solid (570 mg, 56%). M.p.
2,3,11,12,20,21,29,30-Octakis(butoxycarbonyl)tetra[6,7]quinoxalino-
porphyrazine Zinc(II) (TQP1): This compound was prepared ac-
cording to general procedure mentioned above by using magnesium
(112 mg, 5.52 mmol) and compound 2 (250 mg, 0.79 mmol).
MgTQP1 was purified by column chromatography on silica (tolu-
ene/pyridine, 10:2) to obtain the Mg intermediate (93 mg,
0.060 mmol). This intermediate was dissolved in chloroform
(15 mL) and p-toluenesulfonic acid (180 mg, 1.05 mmol) in THF
(5 mL) was added; the solution was stirred for 45 min at room tem-
perature. The solvents were evaporated, and the product was thor-
oughly washed with water and acetone. Metallation was performed
according to the general procedure with metal-free TQP (47 mg,
0.031 mmol) and anhydrous zinc acetate (86 mg, 0.47 mmol). Mo-
bile phase toluene/pyridine, 5:1. Blue solid (41 mg, overall yield
16%). 1H NMR (300 MHz, CDCl3/[D5]pyridine, 25 °C): δ = 0.70
(br. s, 24 H, CH3), 1.26 (br. s, 16 H, CH2CH3), 1.59 (br. s, 16 H,
OCH2CH2), 4.28 (br. s, 16 H, OCH2), 9.01 (br. s, 8 H, ArH) ppm.
1
248.5–249.0 °C (MeOH). H NMR (300 MHz, CDCl3, 25 °C): δ =
1.23 (br. s, 24 H, CH3), 2.97 (sept., J = 6.7 Hz, 8 H, CH3CHCH3),
7.29–7.41 (m, 6 H, ArH), 8.08 (s, 2 H, ArH) ppm. 13C NMR
(75 MHz, CDCl3, 25 °C): δ = 151.67, 146.76, 140.13, 139.70,
133.37, 127.25, 124.46, 115.12, 112.36, 27.98, 23.55 ppm. IR (KBr):
ν = 3474, 2965, 2930, 2870, 2238 (CN), 1617, 1588, 1567, 1502,
˜
1456, 1393, 1363, 1346, 1330, 1252, 1230, 1211, 1173, 1157, 1144,
1092, 1062 cm–1. C34H36N4O2 (532.68): calcd. C 76.66, H 6.81, N
10.52; found C 76.44, H 7.06, N 10.57.
5,6-Dineopentylpyrazine-2,3-dicarbonitrile (9): 2,3-Diaminomaleo-
nitrile (848 mg, 8 mmol) was added to a stirred solution of 2,2,7,7-
tetramethyloctane-4,5-dione (400 mg, 2 mmol) in glacial acetic acid
(20 mL), and the mixture was heated at reflux for 9 h. The solvent
736
www.eurjoc.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2010, 732–739